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HIGHLIGHTS 
• Brain radiation impairs cognition, associated with neuronal degeneration and 
neuroinflammation. 
• Ultra-rapid FLASH produced reduced cognitive deficits vs. conventional delivery 
time. 
• Loss of hippocampal dendritic spines and neuroinflammation were less evident 
after FLASH. 
• These factors may mediate the improved therapeutic index of FLASH brain 
irradiation. 
ABSTRACT 
AIM 
To evaluate the impact of ultra-rapid FLASH mouse whole brain irradiation on 
hippocampal dendritic spines and neuroinflammation, factors associated with cognitive 
impairment after brain irradiation. 
Methods 
We administered 30 Gy whole brain irradiation to C57BL6/J mice in sub-second 
(FLASH) vs. 240 s conventional delivery time keeping all other parameters constant, 
using a custom configured clinical linac. Ten weeks post-irradiation, we evaluated spatial 
and non-spatial object recognition using novel object location and object recognition 
testing. We measured dendritic spine density by tracing Golgi-stained hippocampal 
neurons and evaluated neuroinflammation by CD68 immunostaining, a marker of 
activated microglia, and expression of 10 pro-inflammatory cytokines using a multiplex 
immunoassay. 
RESULTS 
At ten weeks post-irradiation, compared to unirradiated controls, conventional delivery 
time irradiation significantly impaired novel object location and recognition tasks whereas 
the same dose given in FLASH delivery did not. Conventional delivery time, but not 
FLASH, was associated with significant loss of dendritic spine density in hippocampal 
 
 
apical dendrites, with a similar non-significant trend in basal dendrites. Conventional 
delivery time was associated with significantly increased CD68-positive microglia 
compared to controls whereas FLASH was not. Conventional delivery time was 
associated with significant increases in 5 of 10 pro-inflammatory cytokines in the 
hippocampus (and non-significant increases in another 3), whereas FLASH was 
associated with smaller increases in only 3. 
CONCLUSION 
Reduced cognitive impairment and associated neurodegeneration were observed with 
FLASH compared to conventional delivery time irradiation, potentially through decreased 
induction of neuroinflammation, suggesting a promising approach to increasing 
therapeutic index in radiation therapy of brain tumors. 
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Radiation therapy is an important treatment modality for a broad range of brain tumors. 
However, the ability to cure tumors through dose intensity is limited by normal tissue 
injury, particularly when a large volume of the brain (up to the whole brain) must be 
 
 
included in the treatment volume as is the case for many clinical indications. In the 
prospective randomized trial RTOG 0614, 64.9% of patients developed a significant 
decrement in cognitive function by 24 weeks after whole brain radiation therapy [1]. In this 
study, the addition of memantine as a neuroprotective agent reduced the incidence of 
cognitive failure to 53.8%. That hippocampal radiation injury is implicated in the observed 
cognitive impairment is supported by the prospective randomized trial NRG Oncology 
CC001 in which whole brain irradiation with conformal dose reduction to the hippocampus 
combined with memantine reduced cognitive failure at 6 months compared to standard 
whole brain radiation and memantine, from 68.2% to 59.5% in this study [8]. Despite both 
neuroprotection and hippocampal dose reduction, the incidence of significant radiation-
induced cognitive decline remains over 50%. 
Preclinical models replicate the observations in humans in that whole brain irradiation in 
rodents produces measurable chronic cognitive deficits, and these deficits are associated 
with loss of hippocampal neurogenesis and loss of dendritic spine density in hippocampal 
neurons [12], [2], [18], [4]]. These effects appear to be mediated by neuroinflammation, 
particularly microglial activation, which demonstrates a strong radiation dose–response 
and can be at least partially mitigated by anti-inflammatory interventions [13]. Activated 
microglia mediate the secretion of pro-inflammatory cytokines, including interleukin (IL)-
1β, IL-6, and tumor necrosis factor alpha (TNFα) in the hippocampus and other brain 
areas following cranial irradiation [7], [10], [23], [6]. 
Recently, preclinical studies of ultra-rapid “FLASH” radiation delivery have demonstrated 
unexpected sparing of normal organ injury compared to conventional dose rate delivery 
of the same doses, while maintaining equal tumoricidal effects [5], [22]. In the brain, 
FLASH irradiation has been shown to spare hippocampal neurogenesis and non-spatial 
memory in mice [14], [15]. FLASH therefore represents a promising new approach to 
increasing substantially the therapeutic index of radiation therapy solely through 
modifying radiation delivery, but the fundamental mechanisms underlying this effect 
remain poorly understood. 
Using a customized configuration of a clinical high-energy electron linear accelerator to 
enable FLASH irradiation in small animals with favorable dosimetric characteristics [19], 
 
 
we sought to evaluate whether sparing of cognition by FLASH whole brain irradiation is 
associated with corresponding sparing of the integrity of hippocampal dendritic spines 
and decreased neuroinflammation. We isolated total delivery time as the dosimetric 
variable between FLASH and conventional delivery time irradiation, keeping other 
parameters including dose per pulse, number of pulses, irradiation geometry, and beam 
type and energy the same. 
MATERIALS AND METHODS 
STUDY DESIGN 
We assessed whether ultra-rapid (FLASH) whole brain irradiation could mitigate the 
neurodegeneration, neuroinflammation, and associated cognitive deficits observed with 
conventional delivery time irradiation. Mice from a single breeding source (3 months of 
age) were randomly assigned to one of three experimental groups (n = 21–26 mice per 
group): 1. control (no irradiation); 2. conventional delivery time irradiation; and 3. FLASH 
irradiation. Approximately 10 weeks after irradiation, each cohort underwent object 
location and novel object recognition testing to assess the effects on learning and 
memory. Twenty-four hours after behavioral testing, mice were euthanized and their 
brains harvested for morphological and biochemical analyses. We used 
immunohistochemistry to assess the development of radiation-induced microglial 
activation, Golgi staining to determine dendritic spine density, and a multiplex 
immunoassay to determine cytokine levels. 
ANIMALS 
Three-month-old male C57BL6/J mice (Jackson Laboratory, Sacramento, CA) were 
housed at the Stanford Research Animal Facility on a 12/12 light–dark cycle with food 
and water provided ad libitum. Animal care was conducted in accordance with the NIH 
Guide for the Care and Use of Laboratory Animals and this study was approved by the 
Institutional Animal Care and Use Committee of Stanford University. 
BRAIN IRRADIATION 
 
 
Whole brain irradiation was performed using a custom configuration of a clinical linear 
accelerator (Varian Clinac 21EX, Varian Medical Systems, Palo Alto, CA) using an 
electron beam [19]. Fig. 1 depicts the irradiation geometry. Briefly, C57BL6/J mice were 
anesthetized by intraperitoneal injection of ketamine and immobilized in a custom acrylic 
stereotactic positioning frame, constructed for reproducible alignment of the mouse skull 
relative to a lead collimator to shape the beam to cover the whole brain and block the 
eyes. A lateral beam was used to irradiate the whole brain while sparing the pharyngeal 
axis. Gafchromic EBT2 films (Ashland Inc, Covington, KY) were placed in the stereotactic 
frame to record the entrance dose for every mouse. The electron beam energies used 
were 16 and 20 MeV. The relatively uniform depth dose across the width of the mouse 
brain (Fig. 1) of beams with these energies in this irradiation geometry was previously 
characterized [19]. The nominal radiation dose was taken to be the mean entrance dose 
over the irradiation field recorded on film for each mouse. We targeted delivery of 30 Gy 
radiation dose to each mouse brain in a single fraction in delivery times of either 0.1–
0.16 s (FLASH, with average dose rate 200 or 300 Gy/s for 20 or 16 MeV beams, 
respectively) or 240 s (conventional delivery time, with average dose rate 0.13 Gy/s for 
both 16 and 20 MeV beams). In both FLASH and conventional delivery time, the dose 
was delivered in a train of pulses (18 pulses on average) of 2 μs duration, each with an 
average dose per pulse of 1.75 Gy and an average intra-pulse dose rate of 
8.75 × 105 Gy/s. The delivery time was varied by controlling the pulse rate: 108 (for 
20 MeV beam) or 180 (for 16 MeV beam) pulses per second for FLASH; and 5 trains of 
2–3 pulses each (delivered at a rate of 18 pulses per second for both 16 and 20 MeV 
beams) separated by 60 s for a total delivery time of 240 s for conventional delivery time. 
 
 
 
 
 
 
Fig. 1. Irradiation geometry. (A) A lead collimator shapes the electron radiation field to 
cover the whole brain while blocking the eyes and pharyngeal axis. (B) The mouse is 
placed in a stereotactic positioning frame and the whole brain is irradiated via a lateral 
field (left), with film measurement of entrance dose for every irradiation. A double 
exposure lateral radiograph (right) demonstrates alignment of the collimated beam 
relative to the mouse. 30 Gy whole brain irradiation was administered in either 0.1–0.16 s 
(FLASH) or 240 s (conventional delivery time) by varying the pulse rate, keeping all other 
parameters constant. (C) Films at the beam entrance and at 1 cm depth in a solid water 
phantom exposed at 20 MeV electron energy, with corresponding transverse dose 
profiles, demonstrate dose homogeneity throughout the field (left). Central axis depth 
dose measured in a solid water phantom is relatively constant over the depth of the brain 
at both 16 and 20 MeV electron energy (right). 
OBJECT LOCATION AND NOVEL OBJECT RECOGNITION TESTING 
On the habituation day and the following 2 test days, mice were acclimated to the dimly 
lit testing room for 30 min in their home cages. They were also habituated to the empty 
45 × 38 × 28 cm testing arena covered by a white cloth for 10 min the day before testing. 
Object location: the ability of the mice to detect the new location of a familiar object was 
assessed on Testing Day 1 (Fig. 2A). Mice were placed in the arena with 2 unfamiliar 
objects positioned 5 cm away from the walls and were allowed to explore the arena and 
the objects for 10 min (Training). One hour after training, one of the familiar objects was 
 
 
moved to a new location and mice were again allowed to explore for 10 min. Novel object 
recognition: twenty-four hours later (Testing Day 2), the familiar object that remained in 
the same location on Testing Day 1 was replaced with a novel object. Mice were allowed 
to explore the arena and the objects for 10 min [11]. The arena and objects were cleaned 
with 70% ethanol between each mouse exploration session and each session was 
recorded using a video recorder attached to the side of the arena. The duration of time 
spent exploring each object, defined as sniffing with the head within 1 cm of the object, 
was recorded by an experimenter blind to the treatment conditions. Mice were excluded 
if they failed to explore the objects for more than the a priori threshold of one minute 
during the training session. A discrimination index was calculated using the following 
equation: discrimination index = [(novel object or location exploration time − familiar object 
or location exploration time)/total time spent exploring objects]*100. Statistical 
significance of difference between treatment groups was determined using a one-way 
ANOVA with Fisher’s LSD post-hoc test. 
 
Fig. 2. FLASH irradiation is associated with reduced deficits in spatial and non-spatial 
object recognition 10 weeks post-irradiation. (A) Schema of novel object location and 
novel object recognition assays. (B) Novel object location: mice given conventional 
 
 
delivery time irradiation (n = 25) spent significantly less time with a familiar object in a 
novel location than control mice (n = 20; *p = 0.017). Mice given FLASH irradiation (n = 26) 
performed similarly to controls and explored the novel location significantly more than 
conventional delivery time irradiated mice (+p = 0.049), indicating sparing of 
hippocampus-dependent spatial learning and memory. (C) Novel object recognition: mice 
given conventional delivery time irradiation explored a novel object significantly less than 
controls (*p = 0.04) while those given FLASH irradiation performed similarly to controls 
(p = 0.67); novel object recognition was non-significantly decreased after conventional 
delivery time irradiation compared to FLASH (p = 0.17). Discrimination index = [(novel 
object or location exploration time − familiar object or location exploration time)/total time 
spent exploring objects]*100%. Statistical significance of differences between treatment 
groups was determined using a one-way ANOVA with Fisher’s LSD post-hoc test. Results 
are plotted as mean ± SEM. 
MODIFIED GOLGI STAINING AND QUANTITATION OF DENDRITIC SPINE DENSITY 
Modified Golgi staining was performed as described previously [21], [20] on one brain 
hemisphere from each mouse of one cohort of mice. Briefly, brains were immersed in 
modified Golgi-Cox staining solution (purchased from Drs. Deqiang Jing and Francis Lee 
at Cornell University) for 9 days. They were transferred to 30% sucrose in dH2O at 4 °C 
for 72 h. Brains were then cut into 150 μm sections with a vibratome while immersed in 
30% sucrose at room temperature. Sections were mounted onto slides coated with 0.3% 
gelatin, dipped in 40% sucrose 3 times, and allowed to air dry for 72 h. Sections were 
washed with dH2O, stained with developing solution, dehydrated with graded ethanols, 
immersed in histoclear, and then coverslipped using DPX mounting medium. 
Dendritic spine density was determined by manually tracing all branches on all dendritic 
trees of Golgi-stained CA1 pyramidal cells in the dorsal hippocampus while viewing and 
adjusting focus at 100× using Neurolucida neuron tracing software (MBF Bioscience, 
Williston, VT). Three neurons per mouse that minimally overlapped adjacent neurons and 
did not appear to be truncated prematurely due to sectioning were selected for tracing. 
Neurolucida Explorer software (MBF Bioscience) was used to determine the density of 
spines on dendritic branches of third order and higher as first and second order dendrites 
 
 
have very few spines. Statistical significance of differences between treatment groups 
was determined using a one-way ANOVA with Fisher’s LSD post-hoc test. 
HISTOLOGY AND IMMUNOHISTOCHEMISTRY FOR MICROGLIAL ACTIVATION 
Immunohistochemistry (IHC) for CD68 (a specific marker for activated microglia) was 
performed as follows: mice were euthanized with carbon dioxide and perfused with 
phosphate-buffered saline (PBS). The brains were then harvested, embedded and frozen 
in OCT (Sakura Fintek, Torrance, CA, USA) using dry ice and stored at −80 °C until 8 µm 
sections were cut with a cryostat onto slides. The primary antibody used was rat 
monoclonal anti-mouse CD68 (Abcam, Cambridge, MA, USA), diluted at 1:1000 in the 
blocking solution. The secondary antibody used was goat anti-rat IgG Alexa Fluor 488 
(Invitrogen, Carlsbad, CA, USA). The staining procedure was based on standard IHC 
techniques for frozen sections. Briefly, the sections were placed in paraformaldehyde 
(4%) for 15 min and then in PBS containing NH4Cl (50 mM) for 5 min. They were 
subsequently transferred into chilled methanol–acetone (1:1 at −20 °C) for 5 min, followed 
immediately by Triton-X 100 (0.1 % in PBS) for 5 min. Blocking was performed with 5% 
goat serum in PBS containing 0.5% Tween 20 for 30 min and immediately incubated with 
the primary antibody at room temperature for 1 h followed by incubation with the 
fluorescent dye-labeled secondary antibody, also for 1 h. The sections were washed 
extensively with PBS after every step. They were then mounted in DAPI-containing 
medium and imaged with an epifluorescence microscope (Carl Zeiss Inc., Oberkochen, 
Germany). For each of 6 mice per treatment group (unirradiated control, conventional 
delivery time, and FLASH), two hemi-brain coronal sections through the hippocampus 
were imaged by automated acquisition of intermediate-power fields (IPFs, 20×) that were 
stitched together to form the whole image of each section. Images were analyzed with 
ImageJ software (https://imagej-nih-gov.proxy.ulib.uits.iu.edu/ij/index.html). CD68-
positive cells were counted in every 20× IPF covering the hippocampus on each section, 
approximately 36–40 IPFs per section, by an observer blinded to the treatment group. 
The total number of CD68-positive cells (±SEM) was scored for each mouse in each 
treatment group. Statistical significance of differences between treatment groups was 
determined using a one-way ANOVA with Fisher’s LSD post-hoc test. 
 
 
CYTOKINE ASSAY 
After perfusion with saline and brain extraction, the hippocampus was dissected from one 
brain hemisphere per mouse in the analysis cohorts and flash frozen at −80 °C until use 
for cytokine measurement. Flash frozen hippocampi were sonicated in RIPA lysis buffer 
containing protease and phosphatase inhibitors. Levels of 10 cytokines were measured 
in hippocampal lysates from each treatment group run in duplicate using a V-PLEX 
Proinflammatory Panel 1 Mouse Kit (Meso Scale Diagnostics, Rockville, MD), which is a 
multiplex sandwich immunoassay with electrochemiluminescence (ECL), according to the 
kit instructions. Discovery Workbench 4.0 software (Meso Scale Diagnostics) was used 
to generate a calibration curve to which ECL signals were fit to determine analyte 
concentrations. 
RESULTS 
The measured entrance dose based on film dosimetry was 30.8 ± 0.09 Gy (mean ± SEM) 
for conventional delivery time and 30.4 ± 0.37 Gy for FLASH irradiation. 
Regarding the impact of FLASH and conventional delivery time irradiation on cognitive 
function, ten weeks post-irradiation the performance of mice on spatial and non-spatial 
variants of the object recognition task was assessed. This unsupervised learning task 
exploits the animal’s innate proclivity to explore novel environmental stimuli. The spatial 
variant is hippocampus-dependent and involves discerning a familiar object in a novel 
location. One mouse was removed from the control group and one mouse was removed 
from the conventional delivery time irradiation group since they failed to explore the 
objects for more than the a priori threshold of one minute during the training session. 
Mice irradiated with conventional delivery time spent significantly less time exploring the 
familiar object in the novel location compared to non-irradiated control mice (Fig. 2B). 
This memory impairment was reduced in mice exposed to FLASH irradiation as their 
exploration of the object in the novel location was significantly greater than mice with 
conventional delivery time irradiation and did not differ significantly from controls (Fig. 
2B). The non-spatial variant of the task is standard novel object recognition and the brain 
areas involved in mediating this task include the perirhinal and prefrontal cortices. 
 
 
Conventional delivery time irradiation significantly decreased the ability of the mice to 
distinguish the novel object from the familiar one (Fig. 2C). The discrimination index after 
FLASH irradiation was not significantly different from controls, though the increase over 
conventional delivery time also did not reach statistical significance. All mice explored the 
objects for similar amounts of time during training, indicating that mobility or 
bias/preference were not likely contributors to the differential exploration of object/location 
during testing. The times spent exploring objects during training were (mean ± SEM): 
unirradiated controls, 89.1 ± 9.7 s; conventional delivery time, 77.1 ± 5.6 s; FLASH, 
78.7 ± 9.3 s. Thus, FLASH irradiation may be particularly effective in sparing 
hippocampus-dependent spatial learning and memory. 
Dendritic spines are highly plastic and critical for memory formation. Conventional 
delivery time radiation has been shown to decrease dendritic spines in the dentate gyrus 
of the rat hippocampus [2], [18], [4]. Given that FLASH irradiation had hippocampus-
dependent memory sparing effects, we investigated its effects on spine density of apical 
and basal dendrites of CA1 pyramidal neurons, as these are the major output cells of the 
hippocampus (Fig. 3A). CA1 apical dendrites integrate spatial and contextual information 
for transmission to other brain regions. At ten weeks post-irradiation, compared to 
unirradiated controls, spine density of apical dendrites was significantly reduced by 
18 ± 4.9% with conventional delivery time but not FLASH irradiation (Fig. 3B and C), 
though the increase in apical dendritic spine density with FLASH over conventional 
delivery time did not reach statistical significance. The spine density of basal dendrites 
after FLASH was intermediate between those of controls and conventional delivery time, 
but these differences did not reach statistical significance (Fig. 3C). 
 
 
 
Fig. 3. FLASH irradiation is associated with reduced dendritic spine loss in the 
hippocampus 10 weeks post-irradiation. (A) Left: representative low power (10×) image 
of Golgi staining of pyramidal neurons in the CA1 hippocampal region of a mouse that 
received FLASH irradiation. Scale bar = 50 µm. Right: representative high power (100×) 
image of Golgi-stained spines of an apical dendrite of a CA1 pyramidal neuron in the 
hippocampus of a mouse that received FLASH irradiation. Scale bar = 5 µm. (B) 
Representative tracings of hippocampal neurons demonstrate loss of dendritic spine 
density after conventional delivery time irradiation but relative sparing after FLASH 
irradiation. (C) Compared to unirradiated controls (n = 5 mice), conventional delivery time 
irradiation (n = 8 mice) significantly decreased the spine density on apical (center) but not 
basal (right) dendrites of CA1 pyramidal neurons of the hippocampus (*p = 0.03). FLASH 
irradiation (n = 8 mice) did not significantly decrease spine density compared to controls 
and apical dendritic spine density was higher with FLASH compared to conventional 
delivery time irradiation, but this difference was not statistically significant (p = 0.08). The 
density of spines was determined for dendritic branches of third order and higher. 
Statistical significance of differences between treatment groups was determined using a 
one-way ANOVA with Fisher’s LSD post-hoc test. Results are plotted as mean ± SEM. 
 
 
Microglial activation is an index of neuroinflammation. At ten weeks post-irradiation, the microglial 
protein CD68, a biomarker of microglial activation, was expressed at significantly higher levels in 
conventional delivery time irradiation vs. unirradiated control mouse brains (Fig. 4A), whereas in 
FLASH it was intermediate between control and conventional delivery time. Mean counts of 
CD68-positive cells per mouse were 132.2 ± 58.4 (mean ± SEM) for unirradiated controls, 
significantly increased to 379 ± 45.5 for conventional delivery time (p = 0.0036), and non-
significantly increased to 255.4 ± 47.9 for FLASH (p = 0.12 vs. control; p = 0.12 vs. conventional 
delivery time, Fig. 4B). 
 
Fig. 4. FLASH irradiation induces less microglial activation 10 weeks post-irradiation. (A) 
Representative sections through the hippocampus with nuclei stained by DAPI (blue) and 
CD68-positive activated microglia appearing as green foci (arrows). Compared to the 
unirradiated control group, conventional delivery time irradiation significantly increased 
microglial activation, whereas FLASH was intermediate between control and conventional 
delivery time. (B) Quantification of CD68-positive cells per hippocampal section (n = 6 
mice each for control and conventional delivery time; n = 5 for FLASH) demonstrating 
significantly increased neuroinflammation after conventional delivery time irradiation 
compared to control (**p = 0.0036), but non-significantly increased after FLASH 
(p = 0.12 vs. control; p = 0.12 vs. conventional delivery time). Statistical significance of 
differences between treatment groups was determined using a one-way ANOVA with 
Fisher’s LSD post-hoc test. Results are plotted as mean ± SEM. The neuroinflammation 
induced in human brain tissue by conventional delivery time radiotherapy involves 
 
 
increased microglial expression of cytokines including IL-6 and TNFα [7], [10], [23], [6]. 
Initially such cytokines may be released to protect neurons but when up-regulated 
chronically they can contribute to delayed radiation neurodegeneration including dendritic 
spine loss and cognitive dysfunction. We measured a panel of ten pro-inflammatory 
cytokine concentrations in the hippocampus. Compared to unirradiated controls, 
conventional delivery time irradiation was associated with statistically significant 
increases in levels of 5 of the 10 cytokines (IL-6, IL-1β, TNFα, KC/GRO, and IL-4), non-
significant increases in another 3 (IL-2, IL-5, and IL-12), and no change in IFN-γ and IL-
10 (Fig. 5). In contrast, FLASH irradiation was associated with significant increases in 
only 3 of the 10 cytokines (IL-1β, TNFα, KC/GRO) over controls, and to a lesser degree 
than conventional delivery time. IL-6 and IL-1β levels were significantly lower and 
KC/GRO levels trended lower (p = 0.07) with FLASH than with conventional delivery time. 
Another 5 cytokines were non-significantly lower with FLASH than with conventional 
delivery time (TNFα, IL-4, IL-2, IL-5, and IL-12). Overall, FLASH was associated with 
decreased neuroinflammation compared to conventional delivery time as demonstrated 
by reductions in microglial activation (CD68) and levels of certain key pro-inflammatory 
cytokines.  
 
Fig. 5. FLASH irradiation induces lower pro-inflammatory cytokine levels in the 
hippocampus 10 weeks post-irradiation. Compared to unirradiated controls (n = 10 mice), 
conventional delivery time irradiation (n = 7 mice) was associated with statistically 
 
 
significant increases in levels of 5 of the 10 cytokines tested (IL-6, IL-1β, TNFα, KC/GRO, 
and IL-4) and non-significant increases in another 3 (IL-2, IL-5, and IL-12). In contrast, 
FLASH irradiation (n = 10 mice) was associated with significant increases in only 3 of the 
10 cytokines (IL-1β, TNFα, KC/GRO) over controls, and to a lesser degree than 
conventional delivery time. IL-6 and IL-1β levels were significantly lower and KC/GRO 
levels trended lower (p = 0.07) with FLASH than with conventional delivery time. Another 
5 cytokines were non-significantly lower with FLASH than with conventional delivery time 
(TNFα, IL-4, IL-2, IL-5, and IL-12). *p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001 compared to 
controls. +p < 0.05 compared to conventional delivery time irradiation. Statistical 
significance of differences between treatment groups was determined using a one-way 
ANOVA with Fisher’s LSD post-hoc test. Results are plotted as mean ± SEM. Discussion 
We demonstrated in this study that, consistent with prior studies [14], [15], [16], FLASH 
is associated with reduced cognitive deficits compared to conventional delivery time 
irradiation. Concomitant with this functional finding was the observation that the loss of 
hippocampal dendritic spines was similarly reduced with FLASH. Our findings that FLASH 
appeared to be associated with less activation of microglial inflammation and decreased 
hippocampal expression of multiple cytokine mediators of inflammation suggest that the 
differential effects on normal tissues of FLASH compared to conventional delivery time 
irradiation occur at the level of induction of inflammatory responses, leading to sparing of 
the common downstream processes impacting cognitive function. 
Distinguishing technical aspects of our study include the use of a high-energy 16–20 MeV 
electron beam [19], which while similar in nature overall to prior platforms used for FLASH 
studies [9], has an advantage of more uniform depth dose characteristics because of the 
higher beam energy. For experimental tractability, we chose to focus on a limited set of 
parameters to study. In particular, it is unclear which aspect of rapid delivery is the most 
important for producing the FLASH biological phenomenon, as it can be a combination of 
factors including average dose rate, total delivery time, dose per pulse, pulse rate, intra-
pulse dose rate, etc. We chose to isolate delivery time, keeping the beam type and 
energy, irradiation geometry, dose per pulse, and intra-pulse dose rate constant, 
 
 
changing only the pulse rate (and concomitantly overall delivery time and average dose 
rate) between FLASH and conventional delivery time. 
Similarly, we chose to evaluate only one high single fraction dose (30 Gy) where we 
anticipated robust inflammatory, neuroanatomical, and cognitive responses with 
conventional delivery time, and evaluated all endpoints at one time point (10 weeks post-
irradiation). We also focused only on normal tissue rather than tumor effects. Of note, 
while this is a very high single fraction whole brain radiation dose compared to what is 
clinically tolerable in humans, it has been demonstrated in previous studies to be tolerable 
in mice with minimal side effects (provided the pharyngeal axis is excluded from the high 
dose radiation field) at least within the first 2–3 months, exceeding the 10-week 
observation period of our experiments [3], [17]. 
An additional limitation of our study is small sample sizes that constrained the statistical 
power to detect differences in a number of the endpoints. Nevertheless, the insights 
gained from this study will inform future investigations into the phenomenological and 
underlying mechanistic aspects of FLASH irradiation. 
In conclusion, our study demonstrated that compared to conventional delivery time 
irradiation, FLASH irradiation was associated with reduced cognitive deficits, potentially 
through ameliorating neuroinflammation and consequently less loss of hippocampal 
dendritic spine density. Further elucidation of the mechanisms underlying these effects 
will facilitate ultimate clinical translation of a new strategy for improving the therapeutic 
index of radiation therapy for cancer. 
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